Account
Articles
21.04.2016
Pharma preparing for NICE and EMA submissions

Pharma companies must start preparing its NICE submission at the time of making the regulatory subm...

Read more
News
30.03.2016
PMA Perspectives Newsletter- March 2016

Topics include our perspectives on an EU commission report on how international reference pricing ca...

Read more
Articles
01.03.2016
Will the CDF proposals force pharma to prepare for...

From July 2016 NICE will gain decision power by saying yes, no or maybe to cancer drugs entering the...

Read more
Articles
24.07.2015
Cancer Drug Fund remit

The proposal states that the CDF should become a "managed access" fund for new cancer dugs, with cle...

Read more
News
21.07.2015
PMA Presentation July 2015

In this issue is an overview of the future changes to the UK Cancer Drug Fund as well as approaches ...

Read more
Articles
15.07.2015
The future of the Cancer Drug Fund

NHS England have recently proposed that NICE should take a more direct role in determining which pro...

Read more
Articles
28.02.2015
New frontiers for Avastin

New legislation has enabled AIFA to approve reimbursement for Avastin for off-label usage in the tre...

Read more
News
27.02.2015
Includes Biosimilar discounts, recent developments

This issue includes topics such as the recent AIFA approval of Avastin for off label use in Wet-AMD ...

Read more
News
19.02.2015
Should the UK have a cost per QALY threshold

Should the UK have a cost per QALY threshold

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.